However, a study specifically examining MLL-AF4+ infant B-ALL found that only the more mature CD34+CD19+ and CD34−CD19+ populations were capable of engraftment [127]. The gene discussed is CD19; the disease is precursor B-cell acute lymphoblastic leukemia.